Katkó Mónika

1.

Makhoul, S., Galgóczi, E., Katkó, M., Aranyosi, J. K., Széll, N., Horváth, S., Orsós, I., Molnár, Z., Fodor, M., Nagy, E. V., Ujhelyi, B.: Effect of Prostaglandin Analogues on Hyaluronan Production of Orbital Fibroblasts.
Biomedicines. 14 (9), 1-18, (cikkazonosító: 2128), 2026.

doi DEA WoS Scopus

Folyóirat-mutatók:

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2025)

Q1 Medicine (miscellaneous) (2025)

2.

Katkó, M., Gazdag, A., Szentpéteri, A., Lőrincz, H., Galgóczi, E., Erdei, A., Berta, E., Bodor, M., Nagy, E. V., Harangi, M.: The Effect of Iatrogenic Hypothyroidism on Lipoprotein Subfractions and Markers of HDL Function in Patients with Differentiated Thyroid Carcinoma.
Life. 16 (7), 1-14, (cikkazonosító: 1083), 2026.

doi DEA WoS Scopus

Folyóirat-mutatók:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2025)

Q1 Ecology, Evolution, Behavior and Systematics (2025)

Q1 Paleontology (2025)

Q2 Space and Planetary Science (2025)

3.

Molnár, Z., Galgóczi, E., Katkó, M., Kolozsi, A., Kovács, R., Rusznák, M., Bodor, M., Nagy, E. V.: Úton a jódhiány végleges felszámolása felé Magyarországon.
Orv. hetil. 167 (26), 1027-1033, 2026.

doi DEA WoS Scopus

Folyóirat-mutatók:

Q4 Medicine (miscellaneous) (2025)

4.

Galgóczi, E., Katkó, M., Borbély, S., Orsós, I., Molnár, Z., Ujhelyi, B., Steiber, Z., Nagy, E. V.: Agarose Gel Electrophoresis Reveals the Molecular Weight Distribution of Hyaluronan Produced by Orbital Fibroblasts.
Gels. 11 (6), 1-15, (cikkazonosító: 406), 2025.

doi DEA WoS Scopus

Folyóirat-mutatók:

Q2 Bioengineering

Q2 Biomaterials

Q1 Organic Chemistry

Q1 Polymers and Plastics

5.

Csiha, S., Hernyák, M., Molnár, Á., Lőrincz, H., Katkó, M., Paragh, G., Bodor, M., Harangi, M., Sztanek, F., Berta, E.: Alpha-Lipoic Acid Treatment Reduces the Levels of Advanced End Glycation Products in Type 2 Diabetes Patients with Neuropathy.
Biomedicines. 13 (2), 1-16, (cikkazonosító: 438), 2025.

doi DEA WoS Scopus

Folyóirat-mutatók:

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q1 Medicine (miscellaneous)

6.

Cogoi, B., Esze, R., Somodi, S., Shemirani, A. H., Bereczky, Z., Muszbek, L., Paragh, G., Katkó, M., Káplár, M.: Protective Effect of Factor XIII Intron-K G Allele on Subclinical Vascular Disease.
Int. J. Mol. Sci. 26 (21), 1-13, (cikkazonosító: 10293), 2025.

doi DEA WoS Scopus

Folyóirat-mutatók:

Q1 Catalysis

Q1 Computer Science Applications

D1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

D1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

7.

Galgóczi, E., Orsós, I., Molnár, Z., Ujhelyi, B., Steiber, Z., Szabó, L., Dienes, B., Csernoch, L., Nagy, E. V., Katkó, M.: Stimulation of Piezo1 Mechanosensitive Channels Inhibits Adipogenesis in Thyroid Eye Disease.
J. Clin. Endocrinol. Metab. 110 (9), 2584-2594, 2025.

doi DEA WoS Scopus

Folyóirat-mutatók:

D1 Biochemistry

D1 Biochemistry (medical)

D1 Clinical Biochemistry

D1 Endocrinology

D1 Endocrinology, Diabetes and Metabolism

D1 Medicine (miscellaneous)

8.

Papp, F. R., Csiki, R., Katkó, M., Galgóczi, E., Steiber, Z., Ujhelyi, B., Nagy, E. V.: Characteristics of hyaluronan metabolism during myofibroblast differentiation in orbital fibroblasts.
EJEA. 101, 20, 2024.

doi DEA

9.

Papp, F. R., Katkó, M., Csiki, R., Galgóczi, E., Molnár, Z., Erdei, A., Bodor, M., Steiber, Z., Ujhelyi, B., Nagy, E. V.: Characteristics of Hyaluronan Metabolism During Myofibroblast Differentiation in Orbital Fibroblasts.
Invest. Ophthalmol. Vis. Sci. 65 (13), 1-12, (cikkazonosító: 13), 2024.

doi DEA WoS Scopus

Folyóirat-mutatók:

Q2 Cellular and Molecular Neuroscience

Q1 Ophthalmology

Q1 Sensory Systems

10.

Galgóczi, E., Molnár, Z., Katkó, M., Ujhelyi, B., Steiber, Z., Nagy, E. V.: Cyclosporin A inhibits PDGF-BB induced hyaluronan synthesis in orbital fibroblasts.
Chem.-Biol. Interact. 396, 1-7, (cikkazonosító: 111045), 2024.

doi DEA WoS Scopus

Folyóirat-mutatók:

Q1 Medicine (miscellaneous)

Q1 Toxicology

11.

Káplár, M., Esze, R., Rajnai, L., Képes, Z., Balkay, L., Somodi, S., Paragh, G., Katkó, M., Emri, M., Garai, I., Fülöp, P.: Impact of liver fat content on serum levels of plasminogen activator inhibitor-1, fibroblast growth factor 21 and cerebral microcirculation in type 2 diabetes and obesity.

DEA

12.

Berta, E., Halmi, S., Molnár, I., Hutkai, D., Csiha, S., Bhattoa, H. P., Lőrincz, H., Somodi, S., Katkó, M., Harangi, M., Paragh, G., Nagy, E. V., Bodor, M.: Low Serum Fibroblast Growth Factor 21 Level and Its Altered Regulation by Thyroid Hormones in Patients with Hashimoto's Thyroiditis on Levothyroxine Substitution.
Metabolites. 14 (10), 1-10, (cikkazonosító: 565), 2024.

doi DEA WoS Scopus

Folyóirat-mutatók:

Q2 Biochemistry

Q2 Endocrinology, Diabetes and Metabolism

Q2 Molecular Biology

13.

Galgóczi, E., Orsós, I., Molnár, Z., Ujhelyi, B., Steiber, Z., Szabó, L., Dienes, B., Csernoch, L., Nagy, E. V., Katkó, M.: Modelling of mechanical stimuli through piezo1 receptor activation and its effect on adipogenic differentiation of orbital fibroblasts.
EJEA. 101, 37, (cikkazonosító: 0101), 2024.

doi DEA

14.

Sinkó, R., Katkó, M., Tóth, G., Kovács, G. L., Dohán, O., Fülöp, T., Costa, P., Dorogházi, B., Kővári, D., Nagy, E. V., Fekete, C., Gereben, B.: Novel biomarkers reveal mismatch between tissue and serum thyroid hormone status in amiodarone-induced hyperthyroidism.
J. Clin. Endocrinol. Metab. 110 (2), 374-386, 2024.

doi DEA Scopus

Folyóirat-mutatók:

D1 Biochemistry

D1 Biochemistry (medical)

D1 Clinical Biochemistry

D1 Endocrinology

D1 Endocrinology, Diabetes and Metabolism

D1 Medicine (miscellaneous)

15.

Csiki, R., Papp, F. R., Galgóczi, E., Steiber, Z., Ujhelyi, B., Nagy, E. V., Katkó, M.: Production of chemerin by orbital fibroblasts during myofibroblast and adipocyte differentiation.
EJEA. 101, 38, 2024.

doi DEA

16.

Csiha, S., Molnár, I., Halmi, S., Hutkai, D., Lőrincz, H., Somodi, S., Katkó, M., Harangi, M., Paragh, G., Nagy, E. V., Berta, E., Bodor, M.: Advanced glycation end products and their soluble receptor (sRAGE) in patients with Hashimoto's thyroiditis on levothyroxine substitution.
Front. Endocrinol. 14, 1-9, (cikkazonosító: 1187725), 2023.

doi DEA WoS Scopus

Folyóirat-mutatók:

Q1 Endocrinology, Diabetes and Metabolism

17.

Kerekes, G., Bodoki, M., Hamar, A. B., Karancsiné Pusztai, A., Tajti, G., Katkó, M., Végh, E., Pethő, Z., Bodnár, N., Horváth, Á., Soós, B., Szamosi, S., Hascsi, Z., Harangi, M., Hódosi, K., Panyi, G., Seres, T., Szűcs, G., Szekanecz, Z.: Effects of 1-year tofacitinib therapy on angiogenic biomarkers in rheumatoid arthritis.
RHEUMATOLOGY. 62 (SI3), SI304-SI312, 2023.

doi DEA WoS Scopus

Folyóirat-mutatók:

D1 Pharmacology (medical)

D1 Rheumatology

18.

Frendl, I., Erdei, A., Zsíros, N., Katkó, M., Galgóczi, E., Németi, Z., Bhattoa, H. P., Kappelmayer, J., Posta, J., Turchányi, B., Urbán, F., Nagy, E. V.: Alcohol consumption affects the late endocrine consequences of mild traumatic brain injury.
Neuroendocrinol. Lett. 43 (4), 239-245, 2022.

DEA WoS Scopus

Folyóirat-mutatók:

Q4 Endocrine and Autonomic Systems

Q4 Endocrinology

Q4 Endocrinology, Diabetes and Metabolism

Q4 Medicine (miscellaneous)

Q4 Neurology

Q4 Neurology (clinical)

Q4 Psychiatry and Mental Health

19.

Csiha, S., Halmi, S., Hutkai, D., Molnár, I., Katkó, M., Lőrincz, H., Harangi, M., Paragh, G., Nagy, E. V., Bodor, M., Berta, E.: Association of chemerin and serum advanced glycation end products in patients with autoimmune thyroiditis.
EJEA. 81, EP400, 2022.

doi DEA

20.

Lengyel, I., Halmi, S., Lőrincz, H., Csiha, S., Katkó, M., Harangi, M., Nagy, E. V., Paragh, G., Bodor, M., Berta, E.: Characterization of fetuin-A levels in patients with autoimmune thyroid disease.
Atherosclerosis. 355, e247-e248, 2022.

doi DEA

21.

Aranyosi, J. K., Galgóczi, E., Erdei, A., Katkó, M., Fodor, M., Ujhelyi, Z., Bácskay, I., Nagy, E. V., Ujhelyi, B.: Different Effects of Cigarette Smoke, Heated Tobacco Product and E-Cigarette Vapour on Orbital Fibroblasts in Graves' Orbitopathy; a Study by Real Time Cell Electronic Sensing.
Molecules. 27 (9), 1-14, 2022.

doi DEA WoS Scopus

Folyóirat-mutatók:

Q2 Analytical Chemistry

Q2 Chemistry (miscellaneous)

Q2 Drug Discovery

Q2 Medicine (miscellaneous)

Q3 Molecular Medicine

Q2 Organic Chemistry

Q1 Pharmaceutical Science

Q2 Physical and Theoretical Chemistry

22.

Galgóczi, E., Katkó, M., Papp, F. R., Csiki, R., Csiha, S., Erdei, A., Bodor, M., Ujhelyi, B., Steiber, Z., Győry, F., Nagy, E. V.: Glucocorticoids Directly Affect Hyaluronan Production of Orbital Fibroblasts: a Potential Pleiotropic Effect in Graves' Orbitopathy.
Molecules. 28 (1), 1-12, (cikkazonosító: 15), 2022.

doi DEA WoS Scopus

Folyóirat-mutatók:

Q2 Analytical Chemistry

Q2 Chemistry (miscellaneous)

Q2 Drug Discovery

Q2 Medicine (miscellaneous)

Q3 Molecular Medicine

Q2 Organic Chemistry

Q1 Pharmaceutical Science

Q2 Physical and Theoretical Chemistry

23.

Taybani, Z., Bótyik, B., Gyimesi, A., Katkó, M., Várkonyi, T.: One-year safety and efficacy results of insulin treatment simplification with in type 2 diabetes.
Endocrino Diabet & Metabol. 6 (1), 1-7, (cikkazonosító: 390), 2022.

doi DEA Scopus

24.

Lőrincz, H., Galgóczi, E., Katkó, M., Ratku, B., Ötvös, T., Harangi, M., Paragh, G., Szabó, Z., Somodi, S.: Plasminogen activator inhibitor-1 level associated with the components of metabolic syndrome in a 4G/5G polymorphism dependent manner.
Atherosclerosis. 355, e248, 2022.

doi DEA

25.

Cogoi, B., Esze, R., Rajnai, L., Somodi, S., Shemirani, A. H., Bereczky, Z., Paragh, G., Katkó, M., Káplár, M.: Protective effect of factor XIII Intron-K G allele on subclinical atherosclerosis.

DEA